Skip to content
value.today
Accuray Incorporated logo

Accuray Incorporated

ARAY
$17 Mmarket cap on Oct 30, 2026-93.7% since Jan 2024
1M
-53.3%
Compare
World rank
#24,824
Revenue
$402 M
For year ending June-2026
Net income
$-49 M
-12.2% margin
SEC filing
Employees
995
As on 2021
value.today research

Accuray Incorporated in brief

Accuray Incorporated is a listed company in the Medical Devices industry, based in California, USA. It was founded in 1990. Its market value was $17 M on 30 October 2026, which makes it the 24,824th largest listed company in the world and the 4,189th largest in the USA on this site. In the year to June 2026 it had sales of $402 M and a net loss of $49 M. It employs about 995 people and Stephen R. La Neve is its chief executive. By market, the largest shares of its 2026 sales came from EIMEA (38%), Americas (22%) and China (17%). Its shares trade under the symbol ARAY (Nasdaq).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About Accuray Incorporated

Accuray is Develops, Manufactures and Sells Radiotherapy Systems company for alternative cancer treatments. The company annual revenue is 754.6 million USD and 947 employees as on 2020. The headquarters is in USA.

Accuray Incorporated timeline

4 events, 1990–2025
  1. 1990
  2. 🏁
    · approximate
    Founded
  3. 2002
  4. •
    · approximate
    First filing with the US SEC
    The company's first electronic filing in SEC EDGAR.
  5. 2007
  6. 🔔
    · approximate
    Initial public offering on Nasdaq
  7. 2025
  8. 💰
    Record revenue of $458 million
    FY2025, the highest of the 9 years on record.

Events of Accuray Incorporated from the company record, SEC EDGAR and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$109 M$217 M$326 M$434 M2020202120222023202420252026

World rank over time

▼ down 10,016 places since 2020
2020-01-01: #14823#14,82320202021-01-01: #12548#12,54820212022-01-07: #15093#15,09320222022-12-25: #18415#18,41520222023-07-30: #14104#14,10420232024-01-05: #16436#16,43620242026-03-08: #10758#10,75820262026-08-01: #20569#20,56920262026-09-30: #22484#22,48420262026-10-30: #24839#24,8392026

Rank in USA: #3,060 (Jan 2020) · #2,974 (Jan 2021) · #3,188 (Jan 2022) · #3,756 (Dec 2022) · #2,884 (Jul 2023) · #3,031 (Jan 2024) · #2,104 (Mar 2026) · #3,851 (Aug 2026) · #3,961 (Sep 2026) · #4,191 (Oct 2026)

Key ratios

market cap and latest results · TTM = trailing 12 months
P/E ratio (TTM)
n/m (loss)
Price / sales (TTM)
0.0×
Price / book
0.4×
Free cash flow yield
-76.3%
Net margin (TTM)
-4.4%
Operating margin
-6.6%
Return on equity
-41.7%
Liabilities / assets
90.6%
Net debt
$107M
Revenue growth
-12.3%
R&D / revenue
9.4%
Revenue per employee
$404 K
Profit per employee
$-49 K

Financial history

USD · fiscal years · source: SEC filings
RevenueNet income
Fiscal year ending Jun 2019: revenue $419M, net income $-16M$419MFY19Fiscal year ending Jun 2020: revenue $383M, net income $4M$383MFY20Fiscal year ending Jun 2021: revenue $396M, net income $-6M$396MFY21Fiscal year ending Jun 2022: revenue $430M, net income $-5M$430MFY22Fiscal year ending Jun 2023: revenue $448M, net income $-9M$448MFY23Fiscal year ending Jun 2024: revenue $447M, net income $-16M$447MFY24Fiscal year ending Jun 2025: revenue $459M, net income $-2M$459MFY25Fiscal year ending Jun 2026: revenue $402M, net income $-49M$402MFY26
Fiscal year endingRevenueGrowthOperating incomeNet incomeNet margin
Jun 2026$402M-12.3%$-26M$-49M-12.2%
Jun 2025$459M+2.7%$8M$-2M-0.3%
Jun 2024$447M-0.2%$1M$-16M-3.5%
Jun 2023$448M+4.1%$2M$-9M-2.1%
Jun 2022$430M+8.5%$8M$-5M-1.2%
Jun 2021$396M+3.5%$22M$-6M-1.6%
Jun 2020$383M-8.6%$13M$4M1.0%
Jun 2019$419M—$1M$-16M-3.9%

Cash flow, debt and per share

Fiscal year endingOperating cash flowCapital spendingFree cash flowEPS (diluted)Dividend / share
Jun 2026$-7M$6M$-13M——
Jun 2025$3M$4M$-1M$-0.02—
Jun 2024$-12M$4M$-16M$-0.16—
Jun 2023$16M$13M$3M$-0.10—
Jun 2022$-2M$5M$-7M$-0.06—
Jun 2021$39M$2M$36M$-0.07—
Jun 2020$-1M$4M$-5M$0.04—
Jun 2019$-30M$4M$-34M$-0.19—

Quarterly results

USD · three months to · source: SEC filings
Revenue, trailing 12 months
$395M
Net income, trailing 12 months
$-17M
RevenueNet income
Three months to Dec 2024: revenue $116M, net income $3M$116MDec ’24Three months to Mar 2025: revenue $113M, net income $-1M$113MMar ’25Three months to Jun 2025 (from the annual report): revenue $128M, net income $1M$128MJun ’25Three months to Sep 2025: revenue $94M, net income $-22M$94MSep ’25Three months to Dec 2025: revenue $102M, net income $-14M$102MDec ’25Three months to Mar 2026: revenue $105M, net income $-12M$105MMar ’26Three months to Jun 2026 (from the annual report): revenue $101M, net income $-2M$101MJun ’26Three months to Sep 2026: revenue $87M, net income $10M$87MSep ’26

Latest quarter to Sep 2026: revenue $87M (-7.9% on a year earlier), net income $10M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Sep 2026.

SEC filings

Official filings of Accuray Incorporated with the US Securities and Exchange Commission.

Annual results

Revenue
$402 M
Operating income
$-26 M
Net income
$-49 M

For year ending June-2026 · source: SEC filing

Balance sheet

Total assets
$444 M
Total liabilities
$402 M
Total equity
$42 M

As of June-2026

Top 92 institutional investors in Accuray Incorporated#

As of Sep 30, 2026
92 institutions held 71.0 M shares (about 59.1% of the shares outstanding) on Sep 30, 2026. The ten largest hold 47.6%. Source: SEC Form 13F filings, filed through Nov 17, 2026. Change is since the previous quarter.This quarter is still being filed: about 99% of the institutions that reported last quarter have filed so far. Institutions that have not filed yet are missing from the list, not sellers; the list is brought up to date every day.
The 25 largest institutional investors in Accuray Incorporated
#InstitutionShares heldChange (shares)% heldValueFiled
1TCW Group Inc27,527,916+8,585,857 (+45.33%)22.91%$7 MNov 10, 2026
2Armistice Capital, LLC5,736,0000 (0.00%)4.77%$2 MNov 16, 2026
3Neuberger Berman Group LLC5,384,817-688,846 (-11.34%)4.48%$1 MNov 13, 2026
4Weber Capital Management LLC /adv4,832,616-100,090 (-2.03%)4.02%$1 MOct 19, 2026
5Vanguard Capital Management LLC4,431,159-6,641 (-0.15%)3.69%$1 MNov 13, 2026
6BlackRock, Inc.2,562,855-703,330 (-21.53%)2.13%$1 MNov 13, 2026
7Renaissance Technologies LLC1,990,284-75,000 (-3.63%)1.66%$1 MNov 12, 2026
8DAFNA Capital Management LLC1,680,5080 (0.00%)1.40%$0 MNov 16, 2026
9FMR LLC1,595,224+219,478 (+15.95%)1.33%$0 MNov 10, 2026
10Millennium Management LLC1,504,733-84,412 (-5.31%)1.25%$0 MNov 16, 2026
11Silverback Asset Management LLC1,450,0000 (0.00%)1.21%$0 MNov 16, 2026
12AQR Capital Management LLC1,434,184-1,284,848 (-47.25%)1.19%$0 MNov 16, 2026
13Geode Capital Management, LLC1,273,249+83,872 (+7.05%)1.06%$0 MNov 6, 2026
14Kovack Advisors, Inc.1,125,979+75,083 (+7.14%)0.94%$0 MNov 13, 2026
15Squarepoint Ops LLC906,179-542,055 (-37.43%)0.75%$0 MNov 9, 2026
16Vanguard Fiduciary Trust Co685,2620 (0.00%)0.57%$0 MNov 13, 2026
17Silverberg Bernstein Capital Management LLC647,915-11,000 (-1.67%)0.54%$0 MOct 13, 2026
18Tenor Capital Management Company, L.P.500,0000 (0.00%)0.42%$0 MNov 16, 2026
19State Street Corp467,466-18,400 (-3.79%)0.39%$0 MNov 12, 2026
20UBS Group AG442,235-1,181,730 (-72.77%)0.37%$0 MNov 10, 2026
21Gsa Capital Partners LLP415,198New0.35%$0 MNov 16, 2026
22Tudor Investment Corp Et Al392,2360 (0.00%)0.33%$0 MNov 16, 2026
23Jpmorgan Chase & Co373,552-3,143 (-0.83%)0.31%$0 MNov 12, 2026
24Goldman Sachs Group Inc328,396-474,561 (-59.10%)0.27%$0 MNov 16, 2026
25Williams & Novak Wealth Management, LLC303,330+65,100 (+27.33%)0.25%$0 MOct 9, 2026
Show all 92: investors 26 to 92
Institutional investors 26 to 92 in Accuray Incorporated
#InstitutionShares heldChange (shares)% heldValueFiled
26North Star Investment Management Corp.264,6200 (0.00%)0.22%$0 MOct 27, 2026
27Northern Trust Corp260,674-2,885 (-1.09%)0.22%$0 MNov 16, 2026
28Assenagon Asset Management S.A.255,886-152,142 (-37.29%)0.21%$0 MOct 15, 2026
29Morgan Stanley239,634-17,399 (-6.77%)0.20%$0 MNov 13, 2026
30Ieq Capital, LLC178,505-154,762 (-46.44%)0.15%$0 MNov 10, 2026
31Barclays PLC167,006-5,633 (-3.26%)0.14%$0 MNov 6, 2026
32Susquehanna International Group, LLP119,607-705,997 (-85.51%)0.10%$0 MNov 16, 2026
33Invesco Ltd.115,842-2,861 (-2.41%)0.10%$0 MNov 12, 2026
34XTX Topco Ltd114,066-46,833 (-29.11%)0.09%$0 MNov 16, 2026
35Wells Fargo & Company/mn111,5000 (0.00%)0.09%$0 MNov 16, 2026
36HSBC Holdings PLC111,4420 (0.00%)0.09%$0 MNov 16, 2026
37Qube Research & Technologies Ltd99,121-248,391 (-71.48%)0.08%$0 MNov 13, 2026
38Bank Of America Corp /de/91,315-19,299 (-17.45%)0.08%$0 MNov 16, 2026
39Simplex Trading, LLC84,592+75,263 (+806.76%)0.07%$0 MNov 4, 2026
40Mariner, LLC79,313-48,129 (-37.77%)0.07%$0 MNov 12, 2026
41Wealth Enhancement Advisory Services, LLC52,151-42,810 (-45.08%)0.04%$0 MOct 13, 2026
42Janney Montgomery Scott LLC50,0320 (0.00%)0.04%$0 MNov 12, 2026
43Cerity Partners LLC49,697-55,038 (-52.55%)0.04%$0 MNov 13, 2026
44Gabelli Funds LLC43,8000 (0.00%)0.04%$0 MNov 12, 2026
45Vanguard Global Advisers, LLC41,2220 (0.00%)0.03%$0 MNov 13, 2026
46Jane Street Group, LLC40,694-2,099,026 (-98.10%)0.03%$0 MNov 12, 2026
47Thrivent Financial for Lutherans34,0800 (0.00%)0.03%$0 MNov 5, 2026
48JMN Financial LLC33,870New0.03%$0 MNov 10, 2026
49Group One Trading LLC29,013New0.02%$0 MNov 10, 2026
50Fidelis Capital Partners, LLC28,047New0.02%$0 MNov 12, 2026
51Mercer Global Advisors Inc /adv25,768-26,522 (-50.72%)0.02%$0 MNov 16, 2026
52BNP Paribas Financial Markets23,768-951 (-3.85%)0.02%$0 MNov 12, 2026
53Two Sigma Investments, LP22,900-500 (-2.14%)0.02%$0 MNov 16, 2026
54SEI Investments Co21,442-593 (-2.69%)0.02%$0 MNov 10, 2026
55Arax Advisory Partners21,353-15,208 (-41.60%)0.02%$0 MNov 12, 2026
56Captrust Financial Advisors21,010-17,609 (-45.60%)0.02%$0 MNov 12, 2026
57Oppenheimer & Co Inc21,0000 (0.00%)0.02%$0 MOct 26, 2026
58Teton Advisors, LLC18,0000 (0.00%)0.01%$0 MNov 12, 2026
59Creative Planning16,406-26,280 (-61.57%)0.01%$0 MNov 2, 2026
60LPL Financial LLC15,892-18,656 (-54.00%)0.01%$0 MNov 6, 2026
61Pallas Capital Advisors LLC15,373-9,240 (-37.54%)0.01%$0 MNov 12, 2026
62Brighton Jones LLC14,304-13,325 (-48.23%)0.01%$0 MNov 3, 2026
63Associated Banc-Corp13,6750 (0.00%)0.01%$0 MOct 30, 2026
64Merit Financial Group, LLC13,471-8,930 (-39.86%)0.01%$0 MNov 6, 2026
65Integrated Wealth Concepts LLC11,832-3,206 (-21.32%)0.01%$0 MNov 17, 2026
66Tower Research Capital LLC (TRC)10,861-43,709 (-80.10%)0.01%$0 MNov 16, 2026
67BFC Planning, Inc.10,2400 (0.00%)0.01%$0 MNov 13, 2026
68Essential Partners LLC5,347-2,022 (-27.44%)0.00%$0 MOct 14, 2026
69Global Retirement Partners, LLC5,188-67 (-1.27%)0.00%$0 MNov 10, 2026
70Citigroup Inc3,609New0.00%$0 MNov 4, 2026
71EverSource Wealth Advisors, LLC2,810-1,977 (-41.30%)0.00%$0 MNov 4, 2026
72Optiver Holding B.V.2,525-868 (-25.58%)0.00%$0 MNov 16, 2026
73Nuveen, LLC2,447New0.00%$0 MNov 10, 2026
74Rockefeller Capital Management L.P.1,879+997 (+113.04%)0.00%$0 MNov 13, 2026
75Fifth Third Bancorp1,826+233 (+14.63%)0.00%$0 MNov 5, 2026
76Farther Finance Advisors, LLC1,422-68 (-4.56%)0.00%$0 MOct 8, 2026
77Osaic Holdings, Inc.1,0000 (0.00%)0.00%$0 MNov 12, 2026
78Larson Financial Group LLC9200 (0.00%)0.00%$0 MNov 5, 2026
79True Wealth Design, LLC852-805 (-48.58%)0.00%$0 MOct 13, 2026
80Fairscale Capital, LLC4790 (0.00%)0.00%$0 MNov 4, 2026
81Fortitude Family Office, LLC419-220 (-34.43%)0.00%$0 MOct 14, 2026
82Steward Partners Investment Advisory, LLC400New0.00%$0 MNov 13, 2026
83Rothschild Investment LLC331-417 (-55.75%)0.00%$0 MNov 10, 2026
84Strategic Financial Concepts, LLC229New0.00%$0 MNov 16, 2026
85Royal Bank Of Canada161-442 (-73.30%)0.00%$0 MNov 16, 2026
86Provenance Wealth Advisors, LLC151New0.00%$0 MOct 30, 2026
87PNC Financial Services Group, Inc.125-18 (-12.59%)0.00%$0 MNov 6, 2026
88SBI Securities Co., Ltd.1040 (0.00%)0.00%$0 MOct 22, 2026
89HighMark Wealth Management LLC1000 (0.00%)0.00%$0 MNov 17, 2026
90Hantz Financial Services, Inc.250 (0.00%)0.00%$0 MNov 9, 2026
91SJS Investment Consulting Inc.25-90 (-78.26%)0.00%$0 MOct 26, 2026
92Jones Financial Companies Lllp240 (0.00%)0.00%$0 MNov 13, 2026

Mutual funds holding Accuray Incorporated#

53 funds hold shares worth $3 M (about 8.7% of the company). Since their previous reports 9 added shares and 65 sold, selling $2 M net.
Mutual funds holding Accuray Incorporated
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 Vanguard Total Stock Market Index FundThe Vanguard Group, Inc.3.12 M$1 M2.6%<0.01%no changeJun 30, 2026
🇺🇸 Neuberger Intrinsic Value FundNeuberger Berman Investment Advisers LLC1.41 M$1 M1.2%0.04%−0.1%May 31, 2026
🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc.1.19 M$0 M0.99%<0.01%−0.4%Jun 30, 2026
🇺🇸 Fidelity Enhanced Small Cap Core ETFFidelity Management & Research Company LLC1.19 M$0 M0.99%<0.01%+11%Jun 30, 2026
🇺🇸 Vanguard Russell 2000 Index FundThe Vanguard Group, Inc.510,134$0 M0.42%<0.01%+4.0%May 31, 2026
🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC471,154$0 M0.39%<0.01%−0.8%May 31, 2026
🇺🇸 Column Small Cap Select FundTrust for Professional Managers381,882$0 M0.32%<0.01%+0.3%May 31, 2026
🇺🇸 iShares Russell 2000 ETFBlackRock Fund Advisors360,909$0 M0.30%<0.01%−86%Jun 30, 2026
🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC181,282$0 M0.15%<0.01%no changeMay 31, 2026
🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC157,905$0 M0.13%<0.01%no changeMay 31, 2026
🇺🇸 Morgan Stanley Pathway Small-Mid Cap Equity ETFCONSULTING GROUP ADVISORY SERVICES LLC143,098$0 M0.12%<0.01%−4.9%May 31, 2026
🇺🇸 Goldman Sachs Absolute Return Tracker FundGoldman Sachs Asset Management, L.P.181,931$0 M0.15%<0.01%+525%Jun 30, 2026
🇺🇸 VIP Disciplined Small Cap PortfolioFidelity Management & Research Company LLC178,351$0 M0.15%<0.01%no changeJun 30, 2026
🇺🇸 Vanguard Russell 2000 Growth Index FundThe Vanguard Group, Inc.92,024$0 M0.08%<0.01%+2.9%May 31, 2026
🇺🇸 iShares Russell 2000 Growth ETFBlackRock Fund Advisors126,442$0 M0.11%<0.01%−85%Jun 30, 2026
🇺🇸 Invesco RAFI US 1500 Small-Mid ETFInvesco Capital Management LLC118,243$0 M0.10%<0.01%−9.5%Jul 31, 2026
🇺🇸 Column Small Cap FundTrust for Professional Managers64,784$0 M0.05%<0.01%no changeMay 31, 2026
🇺🇸 Small Cap Index FundThe Variable Annuity Life Insurance Company58,388$0 M0.05%<0.01%no changeMay 31, 2026
🇺🇸 Fidelity Nasdaq Composite Index FundFidelity Management & Research Company LLC54,348$0 M0.05%<0.01%no changeMay 31, 2026
🇺🇸 Vanguard Balanced Index FundThe Vanguard Group, Inc.73,249$0 M0.06%<0.01%+20%Jun 30, 2026
🇺🇸 Vanguard Institutional Total Stock Market Index FundThe Vanguard Group, Inc.51,997$0 M0.04%<0.01%no changeJun 30, 2026
🇺🇸 iShares Micro-Cap ETFBlackRock Fund Advisors43,049$0 M0.04%<0.01%−83%Jun 30, 2026
🇺🇸 Diversified Equity Alpha Master PortfolioBlackRock Fund Advisors41,571$0 M0.03%<0.01%−23%Jun 30, 2026
🇺🇸 BlackRock Advantage SMID Cap Fund, Inc.BlackRock Advisors, LLC28,286$0 M0.02%<0.01%no changeJun 30, 2026
🇺🇸 Siit Extended Market Index FundSEI INVESTMENTS MANAGEMENT CORPORATION18,400$0 M0.02%<0.01%no changeMay 31, 2026
🇺🇸 Master Small Cap Index SeriesBlackRock Advisors, LLC26,157$0 M0.02%<0.01%−85%Jun 30, 2026
🇺🇸 TETON Westwood Mighty Mites FundTeton Advisors, LLC18,000$0 M0.01%<0.01%no changeJun 30, 2026
🇺🇸 Bridge Builder Small/Mid Cap Growth FundOLIVE STREET INVESTMENT ADVISERS LLC17,332$0 M0.01%<0.01%no changeJun 30, 2026
🇺🇸 EQ/2000 Managed Volatility PortfolioEquitable Investment Management Group, LLC16,338$0 M0.01%<0.01%−85%Jun 30, 2026
🇺🇸 BlackRock Advantage SMID Cap V.I. FundBlackRock Advisors, LLC14,060$0 M0.01%<0.01%no changeJun 30, 2026
🇺🇸 iShares Russell 2000 Value ETFBlackRock Fund Advisors12,597$0 M0.01%<0.01%−84%Jun 30, 2026
🇺🇸 Vanguard Russell 3000 Index FundThe Vanguard Group, Inc.5,917$0 M<0.01%<0.01%no changeMay 31, 2026
🇺🇸 Vanguard Russell 2000 Value Index FundThe Vanguard Group, Inc.5,055$0 M<0.01%<0.01%+3.7%May 31, 2026
🇺🇸 ProShares Russell 2000 High Income ETFPROSHARE ADVISORS LLC4,663$0 M<0.01%<0.01%+8.7%May 31, 2026
🇺🇸 ProShares Ultra Russell2000PROSHARE ADVISORS LLC3,646$0 M<0.01%<0.01%−41%May 31, 2026
🇺🇸 ProShares UltraPro Russell2000PROSHARE ADVISORS LLC3,678$0 M<0.01%<0.01%−40%May 31, 2026
🇺🇸 iShares Russell 3000 ETFBlackRock Fund Advisors4,455$0 M<0.01%<0.01%−85%Jun 30, 2026
🇺🇸 Small-Cap Index PortfolioPacific Life Fund Advisors LLC3,785$0 M<0.01%<0.01%−85%Jun 30, 2026
🇺🇸 ATM Small Cap Managed Volatility PortfolioEquitable Investment Management Group, LLC3,510$0 M<0.01%<0.01%−85%Jun 30, 2026
🇺🇸 1290 VT Micro Cap PortfolioEquitable Investment Management Group, LLC2,605$0 M<0.01%<0.01%−87%Jun 30, 2026
🇺🇸 NVIT Small Cap Index FundNATIONWIDE FUND ADVISORS2,754$0 M<0.01%<0.01%−85%Jun 30, 2026
🇺🇸 Destinations Small-Mid Cap Equity FundBrinker Capital Investments, LLC1,695$0 M<0.01%<0.01%no changeMay 31, 2026
🇺🇸 Vanguard Growth And Income FundWellington Management Company LLP2,500$0 M<0.01%<0.01%−7.4%Jun 30, 2026
🇺🇸 EQ/Morgan Stanley Small Cap Growth PortfolioEquitable Investment Management Group, LLC2,497$0 M<0.01%<0.01%−85%Jun 30, 2026
🇺🇸 BlackRock Small Cap Index V.I. FundBlackRock Advisors, LLC1,691$0 M<0.01%<0.01%−85%Jun 30, 2026
🇺🇸 JNL/DFA U.S. Core Equity FundJackson National Asset Management, LLC647$0 M<0.01%<0.01%−89%Jun 30, 2026
🇺🇸 JNL/DFA U.S. Small Cap FundJackson National Asset Management, LLC670$0 M<0.01%<0.01%−97%Jun 30, 2026
🇺🇸 PD Small-Cap Growth Index PortfolioPacific Life Fund Advisors LLC916$0 M<0.01%<0.01%−85%Jun 30, 2026
🇺🇸 EQ/Franklin Small Cap Value Managed Volatility PortfolioEquitable Investment Management Group, LLC620$0 M<0.01%<0.01%−85%Jun 30, 2026
🇺🇸 Knights of Columbus U.S. ALL CAP INDEX FUNDKnights of Columbus Asset Advisors LLC613$0 M<0.01%<0.01%+11%Jul 31, 2026
🇺🇸 AST Small-Cap Equity PortfolioAST Investment Services, Inc.530$0 M<0.01%<0.01%−97%Jun 30, 2026
🇺🇸 AZL DFA U.S. Core Equity FundAllianz Investment Management LLC262$0 M<0.01%<0.01%−88%Jun 30, 2026
🇺🇸 LVIP Dimensional U.S. Core Equity 2 FundLincoln Financial Investments Corporation473$0 M<0.01%<0.01%−89%Jun 30, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 53 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

Insider trading at Accuray Incorporated#

Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.

Bought, 12 months
$134 K
3 purchases, 1 insider
Sold, 12 months
$0
0 sales, 0 insiders
Net, 12 months
$134 K
open market only
Insiders on file
49
since
$156 K-$434 K$0Nov 2023: bought $0 (0 trades), sold $99 K (1 trades)Nov 23Dec 2023: bought $0 (0 trades), sold $434 K (7 trades)Jan 2024: bought $0 (0 trades), sold $45 K (2 trades)Jan 24Mar 2024: bought $0 (0 trades), sold $31 K (1 trades)May 2024: bought $156 K (2 trades), sold $0 (0 trades)MayJun 2024: bought $0 (0 trades), sold $5 K (1 trades)Sep 2024: bought $0 (0 trades), sold $17 K (1 trades)SepJun 2025: bought $63 K (1 trades), sold $0 (0 trades)Nov 2025: bought $19 K (1 trades), sold $0 (0 trades)NovFeb 2026: bought $134 K (3 trades), sold $0 (0 trades)
Bought (open market)Sold (open market)Hover a month for the totals
Accuray Incorporated: latest insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed Mika NishimuraDirectorOption exercise+1,415——6,731Form 4
filed James M. HindmanDirectorOption exercise+1,415——8,785Form 4
filed Steven F. MayerDirectorOption exercise+1,415——40,055Form 4
filed Joseph E. WhittersDirectorOption exercise+1,415——18,106Form 4
filed Chan GalbatoDirectorOption exercise+1,415——2,665Form 4
filed Stephen R. La NeveCEO, DirectorOption exercise+312,500——332,500Form 4
filed Michael John MurphyVP, Corporate ControllerOption exercise+37,500——62,999Form 4
filed Stephen R. La NeveCEO, DirectorShares withheld for tax-100,001$0.140$14 K232,499Form 4

Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals

Markets and events: Accuray Incorporated#

Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.

Short interest, 2026-10-30
5.6 M
4.7% of shares · 2.87 days to cover
Shares sold short, last 24 reportsAll stocks →

Trading halts

  • 2026-11-07 00:50 UTC, code T3, resumed 14:00 UTC

Fails to deliver

  • : 38,801 shares at $0.14
  • : 59,026 shares at $0.13
  • : 58,196 shares at $0.13
  • : 55,989 shares at $0.14
  • : 40,508 shares at $0.16

Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables

Accuray Incorporated scorecard#

Passes 4 of the 20 checks that could be worked out: strongest in valuation (2 of 5), weakest in growth (0 of 5). Fiscal year 2026; market cap of Oct 30, 2026.

  • Valuation2 of 5
    • ✗P/E below its peers' medianNo P/EThe company made a loss over the last twelve months.
    • ✓Price to book below its peers' median0.4×Price to book 0.4× against Medical Devices's median of 2.5×.
    • ✓Price to sales below its peers' median0.0×Price to sales 0.0× against Medical Devices's median of 2.4×.
    • ✗Free cash flow yield above 5%-76.3%Free cash flow is -76.3% of the market value.
    • ✗Earnings yield above the 10-year Treasury yieldLossA loss earns nothing against the 10-year Treasury's 5.15% (2026-11-13).
    • –The price assumes slower growth than the last three years'Free cash flow of the last three years is missing or below zero on average.
  • Growth0 of 5
    • ✗Revenue grew in the newest year-12.3%Revenue down 12.3% in fiscal 2026.
    • ✗Revenue up more than 5% a year over three years-3.5%-3.5% a year over the three years to fiscal 2026.
    • ✗Faster growth over three years than its peers' median-3.5%-3.5% a year against Medical Devices's median of 10.8% (73 companies).
    • –Earnings per share grew in the newest yearEarnings per share of two years are not on file.
    • ✗Net income higher than five years earlier-$49 M-$49 M in fiscal 2026 against -$6 M in 2021.
    • ✗Revenue rose in at least four of the last five years3 of 5Revenue rose in 3 of the five years to fiscal 2026.
  • Profitability1 of 5
    • ✗Profitable in the newest year-$49 MNet income -$49 M in fiscal 2026.
    • ✗Profitable in each of the last five years0 of 5Profitable in 0 of the five years to fiscal 2026.
    • ✓Operating margin above its peers' median-6.6%-6.6% against Medical Devices's median of -8.2% (86 companies).
    • ✗Return on equity above 15%-80.1%-80.1% in fiscal 2026.
    • –Return on invested capital above 10%No return on invested capital on file.
    • ✗Operating margin wider than three years earlier-6.6%-6.6% in fiscal 2026 against 0.5% in 2023.
  • Financial health1 of 5
    • ✓Short-term assets cover short-term liabilities1.5×Current ratio 1.50 at the end of fiscal 2026.
    • ✗Debt below equity3.5×Debt to equity 3.55 at the end of fiscal 2026.
    • –Net debt below three years of EBITDANet debt to EBITDA is not on file.
    • ✗Operating income covers interest five times-0.8×Operating income -0.8 times interest in fiscal 2026.
    • ✗Cash from operations positive in each of the last three years1 of 3Positive in 1 of the three years to fiscal 2026.
    • ✗Altman Z-score outside the distress zone-0.80Z-score -0.80 (distress zone) for fiscal 2026.
  • Shareholder returnsnot known
    • –Pays a dividendDividends are not on file.
    • –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
    • –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
    • –Share count up no more than 2% in a yearShare counts of two years are not on file.
    • –Dividends and buybacks above 3% of the market valueDividends and buybacks are not on file.
    • –Free cash flow covers dividends and buybacksPaid out nothing in the newest year.

Worked out from the statements as filed (sec), the medians of Medical Devices, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

Financial analysis, 2026#

Worked out from Accuray Incorporated's statements, beside the median of Medical Devices.

Accuray Incorporated: main financial ratios in 2026
Ratio2026Median of peers
Operating margin-6.6%-8.2%
Net margin-12.2%-10.4%
Return on equity-80.1%-16.8%
Revenue growth, 3 years a year-3.5%10.8%
Revenue growth-12.3%10.4%
Debt to equity3.55×0.64×

1of 9on the Piotroski tests of financial strength

  • Revenue fell 12.3% against the year before.
  • Net loss of $49 million, the 6th loss-making year in a row.
  • Free cash flow was negative: -$13 million.
  • Operating income covers the interest bill only -0.8 times.

Accuray Incorporated: financial statements#

Income statement, balance sheet and cash-flow statement as reported, newest period first.

Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).

Accuray Incorporated: statements by fiscal year
PeriodTrendFY 2026to Jun 30, 2026FY 2025to Jun 30, 2025FY 2024to Jun 30, 2024FY 2023to Jun 30, 2023FY 2022to Jun 30, 2022FY 2021to Jun 30, 2021FY 2020to Jun 30, 2020FY 2019to Jun 30, 2019FY 2018to Jun 30, 2018FY 2017to Jun 30, 2017
Income statement
Revenue402459447448430396383419405383
Cost of revenue290312304294270237233256243242
Gross profit111147143154160160150163162141
Research and development38485057585350565750
Selling and marketing39434346504347566057
General and administrative45485048444240504844
Operating expenses138139142152152137137162165151
Operating income−267.80.52.48.122130.6−3.8−9.8
Interest and finance income0.81.21.2———————
Interest expense and finance costs331312118.11718151517
Provision for credit losses0.6−0.1−0.5———————
Share of profit of associates1.14.71.82.60.20.9−0.1r———
Other non-operating income (expense)5.00.6−2.5−1.1r−2.3r−28−6.7−15−19−19
Income before tax−471.1−12−6.8−2.0−4.65.7−14−23−29
Income tax1.92.73.72.53.31.81.92.10.91.0
Net income including minority interests—−1.6−16−9.3−5.3−6.33.8−16−24−30
Net income attributable to shareholders−49−1.6−16−9.3−5.3−6.33.8−16−24−30
Earnings per share, basic-0.40-0.02-0.16-0.10-0.06-0.070.04-0.19-0.28-0.36
Earnings per share, diluted—-0.02-0.16-0.10-0.06-0.070.04-0.19-0.28-0.36
Shares, weighted average (basic)12310398959292908785—
Shares, weighted average (diluted)—1039895929291878582
Balance sheet
Cash and cash equivalents415769r8989116108778372
Short-term investments—————————24
Receivables678392759485911126673
Inventory147141138145142126134121109105
Other current assets1.12.2r4.01.7r3.6r2221241619
Current assets288317323338351353357344284309
Property, plant and equipment27292521131215172423
Right-of-use (leased) assets2833342617232931——
Goodwill58585858585858r58r5858
Other intangible assets00.00.10.20.30.40.70.70.81.0
Total assets444470469479473480491438379406
Accounts payable41345034311923302017
Debt due within a year1.5137.85.78.63.8———113
Current liabilities191193195199209192182192169284
Long-term debt14612416417217217018916013152
Lease liabilities (non-current)28323224101724———
Total liabilities402389424426420411427388330360
Retained earnings−568−519−518−502−493−488−482−486−474−450
Shareholders' equity42814554536964504947
Total liabilities and equity444470469479473480491438379406
Shares outstanding11911310097939191898684
Cash-flow statement
Depreciation and amortization7.96.25.94.55.56.47.5109.718
Share-based compensation6.5109.510119.38.2111214
Cash from operating activities−7.02.9−1216−2.439−1.5−3018−0.4
Capital expenditure−5.9−4.3−3.6−13−4.7−2.3−3.6−4.3−6.3−5.0
Intangible assets bought——0−0.100−0.2—−0.3−0.3
Cash from investing activities−12−8.5−3.6−13−4.7−2.4−3.7−4.31818
Debt repaid———00−1160—−70−105
Shares issued0.71.62.22.23.93.0————
Shares bought back———00−140———
Cash from financing activities7.0−4.3−4.0−2.1−15−292728−27−55
Exchange-rate effect on cash—1.7−1.40.3−5.61.00.20.1−0.30.2
Change in cash−13−8.3−211.0−288.322−5.48.3−37
Report10-K10-K10-K/A10-K10-K10-K10-K10-K10-K10-K

r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies

Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.

Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative

What Accuray Incorporated sells: revenue by product line, fiscal 2026#

As the company reports it, in US dollars, with each line's share of total revenue and the change on fiscal 2025. Lines can overlap (a total and its parts), so they are not added up.

Products and services

  • Service(total)$229 M57%
  • Product(total)$173 M43%

Countries and regions

Source: SEC annual report (XBRL data) · as of Jun 30, 2026

Where Accuray Incorporated operates: 3 countries#

Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue.

Accuray Incorporated: countries of operation
CountryPresenceRevenue there
🇺🇸 USAHeadquarters1 office—
🇨🇳 China$68 M17%
🇯🇵 Japan$44 M11%

Source: GLEIF legal-entity register, SEC Exhibit 21 and annual reports, office addresses on file. A country without subsidiaries or offices on record is not listed even if the company sells there. How presence is decided

Executive pay at Accuray Incorporated#

From the pay-versus-performance table of the company's proxy statement. “Actually paid” marks share awards to their current value.

CEO total pay, fiscal 2026
$5.2 M
Stephen R. La Neve
Other top executives, average
$738 K
the CEO earned 7.1× this
$100 invested is now
$7
Accuray Incorporated: executive pay by fiscal year
Fiscal yearCEO total payActually paidOther executives, average$100 invested
2026Stephen R. La Neve$5.2 M$1.9 M$738 K$7
2025Stephen R. La Neve$3.0 M$1.2 M$1.2 M$35
2024Suzanne Winter$3.5 M−$126 K$1.2 M$47

Source: SEC proxy statement (Form DEF 14A) · as of Jun 30, 2026

Events at Accuray Incorporated#

What the company reported to the SEC within four business days (Form 8-K), newest first.

Warning signs in the last three years

  • Delisting noticeFiling
  • Financial statements withdrawnFiling
  • Delisting noticeFiling

Delisting notice 2 · Financial statements withdrawn 1 · Restructuring 1 · Directors and officers 12 · Material agreement 5 · Agreement ended 2 · New debt 1 · Unregistered share sale 3 · Shareholder vote 2 · Results announced 8

Accuray Incorporated: events reported to the SEC
FiledWhat happenedFiling
Results announced8-K
Directors and officers8-K
Directors and officersShareholder vote8-K
Results announced8-K
Delisting notice8-K
Directors and officersMaterial agreementUnregistered share sale8-K
Agreement ended8-K
Results announced8-K
Directors and officers8-K
Material agreement8-K
Directors and officers8-K
Financial statements withdrawn8-K
Delisting notice8-K
Results announced8-K
Directors and officers8-K
Directors and officers8-K
RestructuringMaterial agreementUnregistered share sale8-K
Directors and officersShareholder vote8-K
Results announced8-K
Directors and officersMaterial agreementResults announced8-K
Directors and officers8-K
Directors and officers8-K
Results announced8-K
Directors and officersMaterial agreementAgreement endedNew debtUnregistered share sale8-K
Results announced8-K

Source: SEC EDGAR, Form 8-K item numbers · as of Nov 4, 2026

Government contracts: Accuray Incorporated#

$1.3 M in federal contracts in fiscal 2026, mostly from Department of Veterans Affairs.

Contracts, FY2026
$1.3 M
#513 among companies on value.today
Grants, FY2026
—
FY2027 to date
$336 K
contracts and grants
Since FY2008
$62.3 M
contracts and grants
  • Department of Veterans Affairs$1.3 M
Accuray Incorporated: federal obligations by fiscal year
Fiscal yearContractsGrants
FY2027 (to date)$336 K—
FY2026$1.3 M—
FY2025$5.6 M—
FY2024$2.5 M—
FY2023$2.4 M—
FY2022$1.7 M—
FY2021$1.9 M—
FY2020$6.3 M—
FY2019$10.3 M—
FY2018$2.1 M—
FY2017$1.7 M—
FY2016$10.2 M—
FY2015−$2.0 M—
FY2014$12.6 M—
FY2013$3.0 M—
FY2012$1.7 M—
FY2011$727 K—

Source: USAspending.gov. Obligations are binding promises to pay, not payments, and can be negative when an award is cut. Counted under Accuray Incorporated: ACCURAY INCORPORATED (UEI YHK9MN8BK835)

Lobbying by Accuray Incorporated#

$160 K spent on lobbying the US Congress and federal agencies in 2025, most often on medicare/medicaid and trade (domestic/foreign).

Lobbying, 2025
$160 K
#1,081 among companies on value.today
Own lobbyists
No
only outside firms
Firms hired
1
in 2025
2026 so far
$120 K
  • Medicare/Medicaid4 reports
  • Trade (domestic/foreign)4 reports

Lobbying firms hired in 2025

JEFFREY J. KIMBELL AND ASSOCIATES $160 K

Accuray Incorporated: lobbying spending by year
YearSpendingOwn lobbyistsReports
2026 (so far)$120 K—3
2025$160 K—4
2024$160 K—4
2023$160 K—8
2022$190 K—8
2021$250 K—8
2020$240 K—7
2019$160 K—4
2018$160 K—4

Source: Lobbying Disclosure Act reports (Form LD-2). Filed as “Accuray Incorporated” and “Accuray”. Reports round to the nearest $10,000, and one of less than $5,000 counts as zero

H-1B hiring at Accuray Incorporated#

2 labor condition applications certified in fiscal 2026 for 2 positions, at a median wage of $145 K a year.

Certified, FY2026
2
#1,534 among companies on value.today
Worker positions
2
Median wage offered
$145 K
a year, full-time
Applications filed
2
Accuray Incorporated: most frequent H-1B job titles in fiscal 2026
Job titlePositionsMedian wage offered
Director Global Prod Strategy Helical Platform & JV ChinaMarketing Managers1$187 K
Manufacturer Process Capability EngineerManufacturing Engineers1$102 K

Where: Madison, WI 2

Accuray Incorporated: labor condition applications by fiscal year
Fiscal yearCertifiedPositionsMedian wageFiled
FY202622$145 K2
FY202555$157 K5
FY202411$112 K1
FY202388$127 K8
FY202244$126 K4
FY20211010$128 K10
FY202077$138 K9

Source: US Department of Labor, LCA disclosure data. An application is not a visa: USCIS decides each petition later, and the yearly lottery limits new H-1B visas. Filed as Accuray Incorporated, Accuray Incorporated and Accuray Incorporated

Layoffs at Accuray Incorporated#

From US state WARN notices and SEC 8-K restructuring filings, newest first.

People, last 12 months
0
1 notices and filings
People, all years
111
2009–2025
Latest
—
2025-12-12
Accuray Incorporated: people laid off by year and month
YearJanFebMarAprMayJunJulAugSepOctNovDecTotal
2025············—
2023············—
2022············—
2020············—
2018············—
Accuray Incorporated: latest layoffs
AnnouncedPeopleKindWhereSource
15% of workforceRestructuring planSEC 8-K“On December 15, 2025, the Company informed affected employees of such organizational realignment, which resulted in the elimination of approximately 15 percent of the Company’s glo…”Filing
5.9% of workforceRestructuring planSEC 8-K“On October 25, 2023, the Company informed affected employees of such cost savings initiative, which resulted in the elimination of approximately 5.9 percent of the Company’s global…”Filing
4.5% of workforceRestructuring planSEC 8-K“On December 1, 2022, Accuray Incorporated (the “Company”) informed affected employees of a cost saving initiative designed to reduce operating costs through the elimination of appr…”Filing
3% of workforceRestructuring planSEC 8-K“On May 27, 2020, Accuray Incorporated (the “Company”) informed affected employees of a cost saving initiative designed to reduce operating costs through the elimination of approxim…”Filing
5% of workforceRestructuring planSEC 8-K“On October 29, 2018, the Company informed affected employees of a cost saving initiative designed to reduce operating costs through the elimination of approximately 5 percent of it…”Filing
13% of workforceRestructuring planSEC 8-K“On January 3, 2013, in an effort to contain its costs, the Company announced a restructuring of its operations through the elimination of approximately 13 percent of its workforce,…”Filing

Source: State WARN notices and SEC 8-K item 2.05

How Accuray Incorporated compares in Medical Devices

  • Market cap$17 M · higher than 11% of 142
  • Revenue$402 M · higher than 68% of 155
  • Net margin-4.4% · higher than 52% of 144
  • Revenue growth-12.3% · higher than 8% of 104
  • Price / sales0.0× · lowest of 96
  • Price / book0.4× · lowest of 99
  • FCF yield-76.3% · higher than 8% of 76

Peer comparison · Medical Devices

CompanyMarket capP/ENet marginRev. growth
Accuray Incorporated🇺🇸$17 M—-4.4%-12.3%
Abbott Laboratories🇺🇸$181.1 B38.5×9.8%+5.7%
Medtronic plc🇺🇸$121.2 B23.2×13.9%+8.4%
Stryker Corporation🇺🇸$116.5 B32.2×13.8%+11.2%
Boston Scientific Corporation🇺🇸$66.2 B18.9×16.6%+19.9%
Edwards Lifesciences Corporation🇺🇸$52.8 B51.7×15.3%+11.6%
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.🇨🇳$27.8 B23.6×24.4%—
STERIS plc🇮🇪$20.4 B24.6×13.4%+8.7%
Zimmer Biomet Holdings, Inc.🇺🇸$18.2 B23.8×8.9%+7.2%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Oct 30, 2026
Annual results:
For year ending June-2026
Balance sheet:
As of June-2026
Employees:
As on 2021
Profile updated:
Nov 20, 2026

Figures from Market data, SEC filing, value.today research; financial statements from SEC filings.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Accuray Incorporated? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Accuray Incorporated's ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Accuray Incorporated? Suggest a correction